162 related articles for article (PubMed ID: 36632438)
1. Positive Expression of Retinol-Binding Protein 4 Is Related to the Malignant Clinical Features Leading to Poor Prognosis of Glioblastoma.
Deng X; Ren J; Bi Z; Fu Z
Genet Res (Camb); 2022; 2022():5435523. PubMed ID: 36632438
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic significance of TCTN1 in human glioblastoma.
Meng D; Chen Y; Zhao Y; Wang J; Yun D; Yang S; Chen J; Chen H; Lu D
J Transl Med; 2014 Oct; 12():288. PubMed ID: 25304031
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of PSMD family members and validation of PSMD9 as a potential therapeutic target in human glioblastoma.
Li Y; Liu X; Zhao F; Zhao Z; Li X; Wang J; Huang B; Chen A
CNS Neurosci Ther; 2024 Feb; 30(2):e14366. PubMed ID: 37485655
[TBL] [Abstract][Full Text] [Related]
5. Actin-Binding LIM 1 (ABLIM1) Inhibits Glioblastoma Progression and Serves as a Novel Prognostic Biomarker.
Liu D; Wang X; Liu Y; Li C; Zhang Z; Lv P
Dis Markers; 2022; 2022():9516808. PubMed ID: 36583064
[TBL] [Abstract][Full Text] [Related]
6. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
7. LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis.
Xu H; Zhang B; Yang Y; Li Z; Zhao P; Wu W; Zhang H; Mao J
J Cell Mol Med; 2020 Jun; 24(11):6362-6372. PubMed ID: 32319715
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1.
Luo W; Li X; Song Z; Zhu X; Zhao S
Aging (Albany NY); 2019 Jun; 11(11):3811-3823. PubMed ID: 31186379
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CLEC18B Associates With the Proliferation, Migration, and Prognosis of Glioblastoma.
Guo RM; Zhao CB; Li P; Zhang L; Zang SH; Yang B
ASN Neuro; 2018; 10():1759091418781949. PubMed ID: 29914265
[TBL] [Abstract][Full Text] [Related]
10. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
11. miR‑378a‑3p inhibits cellular proliferation and migration in glioblastoma multiforme by targeting tetraspanin 17.
Guo XB; Zhang XC; Chen P; Ma LM; Shen ZQ
Oncol Rep; 2019 Nov; 42(5):1957-1971. PubMed ID: 31432186
[TBL] [Abstract][Full Text] [Related]
12. CFTR activation suppresses glioblastoma cell proliferation, migration and invasion.
Zhong X; Chen HQ; Yang XL; Wang Q; Chen W; Li C
Biochem Biophys Res Commun; 2019 Jan; 508(4):1279-1285. PubMed ID: 30573361
[TBL] [Abstract][Full Text] [Related]
13. MiR-1271 regulates glioblastoma cell proliferation and invasion by directly targeting the CAMKK2 gene.
Huang YK; Su YF; Lieu AS; Loh JK; Li CY; Wu CH; Kuo KL; Lin CL
Neurosci Lett; 2020 Oct; 737():135289. PubMed ID: 32791096
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA‑3666 suppresses the growth and migration of glioblastoma cells by targeting KDM2A.
Shou T; Yang H; Lv J; Liu D; Sun X
Mol Med Rep; 2019 Feb; 19(2):1049-1055. PubMed ID: 30483744
[TBL] [Abstract][Full Text] [Related]
16. Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma.
Martins EP; Gonçalves CS; Pojo M; Carvalho R; Ribeiro AS; Miranda-Gonçalves V; Taipa R; Pardal F; Pinto AA; Custódia C; Faria CC; Baltazar F; Sousa N; Paredes J; Costa BM
Mol Oncol; 2022 Jul; 16(14):2611-2631. PubMed ID: 34919784
[TBL] [Abstract][Full Text] [Related]
17. Musashi-1 Enhances Glioblastoma Migration by Promoting ICAM1 Translation.
Lin JC; Tsai JT; Chao TY; Ma HI; Liu WH
Neoplasia; 2019 May; 21(5):459-468. PubMed ID: 30959276
[TBL] [Abstract][Full Text] [Related]
18. NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma.
Guo Q; Han N; Shi L; Yang L; Zhang X; Zhou Y; Yu S; Zhang M
Oncol Rep; 2019 Sep; 42(3):963-972. PubMed ID: 31322259
[TBL] [Abstract][Full Text] [Related]
19. High Mobility Group Box 1 (HMGB1) Predicts Invasion and Poor Prognosis of Glioblastoma Multiforme via Activating AKT Signaling in an Autocrine Pathway.
Cheng P; Ma Y; Gao Z; Duan L
Med Sci Monit; 2018 Dec; 24():8916-8924. PubMed ID: 30531692
[TBL] [Abstract][Full Text] [Related]
20. Long non‑coding RNA FLVCR1‑AS1 promotes glioma cell proliferation and invasion by negatively regulating miR‑30b‑3p.
Gao W; Li H; Liu Y; Zhang Y; Zhao H; Liu F
Mol Med Rep; 2020 Aug; 22(2):723-732. PubMed ID: 32626942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
